These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification. Urinary Tenascin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback